For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Entire Study Population | All participants (Androgen ablative (AA) therapy + MDX-010 and Androgen ablative (AA) therapy alone the AA Therapy + MDX-010) were grouped together for this outcome. | None | None | 10 | 110 | 107 | 110 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Diarrhea-No Colostom | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Ileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Hepatic | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | MedDRA 6 | View |
| Creatinine | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Vision-Blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 6 | View |
| Pain-Abdominal | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 6 | View |
| Urinary tract infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Ischemia/Infarction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA 6 | View |
| Alkaline phosphatase | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Amylase | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Hypercalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hyperuricemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 6 | View |
| Pneumonitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 6 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Rash/Desquamation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA 6 | View |
| Thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA 6 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA 6 | View |
| Lymph node pain | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDRA 6 | View |
| Cardiovascular | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA 6 | View |
| Ventricular tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA 6 | View |
| Endocrine | SYSTEMATIC_ASSESSMENT | Endocrine disorders | MedDRA 6 | View |
| Vision | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 6 | View |
| Vision-Blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | MedDRA 6 | View |
| Anal hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Colitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Colonic hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Diarrhea-No Colostom | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Duodenal ulcer | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Dyspepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Pain-Abdominal | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 6 | View |
| Constitutional Symptoms | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 6 | View |
| Edema: Limb | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 6 | View |
| Pain-Chest | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 6 | View |
| Rigors | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 6 | View |
| Hepatic | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | MedDRA 6 | View |
| Hypersensitivity | SYSTEMATIC_ASSESSMENT | Immune system disorders | MedDRA 6 | View |
| Abdominal infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Colon infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Lung (pneumonia) infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Penis infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Skin (cellulites) infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Wound infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA 6 | View |
| Bruising (in absence of grade 3 or 4 thrombocytopenia) | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 6 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Alkaline phosphatase | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Amylase | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Lipase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Metabolic/Lab | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Weight loss | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Bicarbonate | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hypercalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hyperuricemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hypoglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | MedDRA 6 | View |
| Extremity-lower necrosis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 6 | View |
| Musculoskeletal | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 6 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 6 | View |
| Cognitive disorder | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 6 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 6 | View |
| Ischemia-Cerebral | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 6 | View |
| Neuro | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 6 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 6 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 6 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 6 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 6 | View |
| Pollakiuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 6 | View |
| Ureteral Obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 6 | View |
| Urinary bladder hemorrhage | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 6 | View |
| Urinary retention | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | MedDRA 6 | View |
| Breast pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA 6 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 6 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 6 | View |
| Pharyngolaryngeal pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 6 | View |
| Pulmonary | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 6 | View |
| Sinus Reactions | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 6 | View |
| Acne | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Decubitus Ulcer | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Dry skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Nail Changes | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Pruritus | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Rash/Desquamation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Urticaria | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA 6 | View |
| Flushing | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA 6 | View |
| Hot flashes | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA 6 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA 6 | View |
| Facial pain | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 6 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 6 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Coagulation | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Creatinine | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA 6 | View |
| Arthritis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 6 | View |
| Back pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 6 | View |
| Bone pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA 6 | View |
| Prostatic pain | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDRA 6 | View |
| Atelectasis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA 6 | View |